MBX Biosciences, Inc. Balance Sheet
MBX / Health Care|2 years of annual SEC 10-K data (FY2023-FY2024)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 2 fiscal years. All figures from audited SEC 10-K filings.
MBX Biosciences, Inc. had $269M in total assets and $257M in shareholders' equity as of FY2024.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score 9.64 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2024 | FY2023 |
|---|---|---|
| Cash & Equivalents | $49.4M | $30.5M |
| Current Assets | $267.3M | $83.5M |
| PP&E (Net) | $1.1M | $439.0K |
| Total Assets | $268.5M | $84.2M |
| Current Liabilities | $11.1M | $3.9M |
| Shareholders' Equity | $257.4M | -$72.5M |